HDFC Bank Dividend: Last Day To Buy Shares To Qualify — Details Here
Shares of HDFC Bank Ltd. will be of interest on Thursday as the day marks the last session for investors to buy shares to qualify for receiving the dividend before the stock goes ex/record-date.
The record date determines shareholders eligible to receive dividend payment. The ex-dividend date, which mostly coincides with the record date, marks when the share price adjusts to reflect the upcoming payout.
HDFC Bank's board announced a dividend of Rs 22 per share for financial year 2025. This is the highest dividend issued by the bank since its listing in 2001. The record date to determine the shareholders eligible for the dividend payout has been fixed as June 27.
The total value of the dividend to be disbursed amounts to around Rs 16,834 crore.
Given India's T+1 settlement cycle, shares purchased on the record date (June 27 in this case) will not be eligible for the dividend payment. Therefore, investors who own shares by June 26 will be the beneficiaries.
In comparison, the company had given a final dividend of Rs 19.50 in May 2024 and Rs 19 in May 2023.
A fall in other income and some rise in expenses led HDFC Bank to report a fall in operating profit by over 9% on the year to Rs 26,537 crore for the quarter ended March.
During January-March, the bank's other income fell by 34% on the year to Rs 12,027 crore and expenses rose by over 4% to Rs 60,364 crore.
However, lower provisions and an improvement in asset quality helped the private sector bank report nearly a 7% year-on-year rise in net profit at Rs 17,616 crore. The bank's bottom line also surpassed the consensus estimate of Rs 16,908 crore projected by analysts surveyed by Bloomberg.
Provisions and contingencies at the bank plunged 76% year over year to Rs 3,193.05 crore.
The bank's net interest income rose 10% on the year to Rs 32,066 crore.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.